The effects of the Korean reference value on the prevalence of osteoporosis and the prediction of fracture risk

被引:7
作者
Lee, Sungwha [1 ]
Choi, Moon-Gi [1 ]
Yu, Jaemyung [2 ]
Ryu, Ohk-Hyun [1 ]
Yoo, Hyung Joon [2 ]
Ihm, Sung-Hee [3 ]
Kim, Doo-Man [4 ]
Hong, Eun-Gyung [5 ]
Park, Kyutae [1 ]
Choi, Myungjin [1 ]
Choi, Hyunhee [1 ]
机构
[1] Hallym Med Univ, Chuncheon Sacred Heart Hosp, Dept Internal Med, Chuncheon Si, Gangwon Do, South Korea
[2] Hallym Med Univ, Gangnam Sacred Heart Hosp, Dept Internal Med, Seoul 150950, South Korea
[3] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Anyang 431796, Gyeonggi Do, South Korea
[4] Hallym Med Univ, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul 134701, South Korea
[5] Hallym Med Univ, Dongtan Sacred Heart Hosp, Dept Internal Med, Hwaseong Si 445907, Gyeonggi Do, South Korea
来源
BMC MUSCULOSKELETAL DISORDERS | 2015年 / 16卷
关键词
Bone mineral density; Fracture risk; FRAX; Korean reference value; Osteopenia; Osteoporosis; Prediction of fracture risk; Prevalence; Reference; T-score; BONE-MINERAL DENSITY; POSTMENOPAUSAL OSTEOPOROSIS; BISPHOSPHONATE THERAPY; REFERENCE-STANDARD; DIAGNOSIS; WOMEN; UPDATE; LONG; MEN; DENSITOMETRY;
D O I
10.1186/s12891-015-0523-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Since the reference value is the core factor of the T-score calculation, it has a significant impact on the prevalence of osteoporosis. The purpose of this study was to determine the effects of using the Korean reference value on the prevalence of osteoporosis and on the prediction of fracture risk. Methods: We used femoral neck bone mineral density (BMD) data from the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011. The Korean reference was identified by the mean and standard deviation of men and women aged 20-29 years. We compared the prevalence and the fracture risk assessment tool (FRAX (TM)) probability obtained from the Korean reference and the NHANES III reference. Results: In men, the prevalence of osteoporosis increased when using the Korean men's reference, and the difference increased up to 9% for those in their 80s. In women, the prevalence increased when using the NHANES III reference, and the difference increased up to 17% for those in their 80s. The reference value also affected the fracture risk probability, and the difference from changing the reference value increased in women and in subjects with more clinical fracture risk factors. In major osteoporotic fractures, the difference of the risk probability was up to 6% in women aged 70-79 years with two clinical risk factors. For femoral neck fractures, the difference was up to 7% in women aged 50-59 years with two clinical risk factors. Conclusions: We confirmed that the reference value had significant effects on the prevalence of osteoporosis and on the fracture risk probability. The KNHANES 2008-2011 BMD data reflected the characteristics of the Korean BMD status well with regard to data size and study design; therefore, these data can be used as reference values.
引用
收藏
页数:13
相关论文
共 30 条
[1]  
[Anonymous], 2014, WHO FRACT RISK ASS T
[2]  
[Anonymous], CLIN GUID PREV TREAT
[3]  
[Anonymous], 2013, About the National Health and Nutrition Examination Survey
[4]   Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference [J].
Baim, Sanford ;
Binkley, Neil ;
Bilezikian, John R. ;
Kendler, David L. ;
Hans, Didier B. ;
Lewiecki, E. Michael ;
Silverman, Stuart .
JOURNAL OF CLINICAL DENSITOMETRY, 2008, 11 (01) :75-91
[5]   Continuing Bisphosphonate Treatment for Osteoporosis - For Whom and for How Long? [J].
Black, Dennis M. ;
Bauer, Douglas C. ;
Schwartz, Ann V. ;
Cummings, Steven R. ;
Rosen, Clifford J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (22) :2051-2053
[6]   Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938
[7]   Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 [J].
Compston, J. ;
Bowring, C. ;
Cooper, A. ;
Cooper, C. ;
Davies, C. ;
Francis, R. ;
Kanis, J. A. ;
Marsh, D. ;
McCloskey, E. V. ;
Reid, D. M. ;
Selby, P. .
MATURITAS, 2013, 75 (04) :392-396
[8]   Bisphosphonate therapy for osteoporosis: The long and short of it [J].
Compston, Juliet E. ;
Bilezikian, John P. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :240-242
[9]   Epidemiology and outcomes of osteoporotic fractures [J].
Cummings, SR ;
Melton, LJ .
LANCET, 2002, 359 (9319) :1761-1767
[10]   Reference Ranges for Bone Mineral Density and Prevalence of Osteoporosis in Vietnamese Men and Women [J].
Ho-Pham, Lan T. ;
Nguyen, Uyen D. T. ;
Pham, Hoa N. ;
Nguyen, Nguyen D. ;
Nguyen, Tuan V. .
BMC MUSCULOSKELETAL DISORDERS, 2011, 12